Molecular Templates, Inc. Faces Delisting from Nasdaq Due to Compliance Issues
Molecular Templates faces delisting from Nasdaq due to non-compliance and plans to suspend trading on December 26, 2024.Quiver AI SummaryMolecular Templates, Inc., a clinical-stage biopharmaceutical company...
Molecular Templates, Inc. Receives Nasdaq Deficiency Notification for Reporting and Bid Price Compliance
Molecular Templates received Nasdaq deficiency notices for late filings and failing to maintain minimum bid price.Quiver AI SummaryMolecular Templates, Inc. has received a notification from Nasdaq indicating...
Stocks Set to Open Lower as Investors Await FOMC Minutes, Inflation Data
June S&P 500 futures (ESM23) are down -0.21%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.34% this morning as market participants assessed recent labor market data while awaiting the release...